Chiusura precedente | 8,20 |
Aperto | 8,20 |
Denaro | N/D |
Lettera | N/D |
Prezzo d'esercizio | N/D |
Scadenza | N/D |
Min-Max giorno | 8,20 - 8,20 |
Contratto - Min-Max | N/D |
Volume | |
Open Interest | N/D |
WYOMISSING, Pa., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (“GLPI” or the “Company”) today announced record results for the fourth quarter and year-ended December 31, 2022. Financial Highlights Three Months Ended December 31,Year Ended December 31, (in millions, except per share data) 2022 Actual 2021 Actual2022 Actual 2021 Actual Total Revenue $336.4 $298.3$1,311.7 $1,216.4 Income From Operations $275.5 $204.4$1,029.9 $841.8 Net income $199.6 $119.6$70
- $209.7 Million Cash and Cash Equivalents at March 31, 2022 – - Over 120 Patients Now Enrolled in Phase 3 Program - AUSTIN, Texas, May 05, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the first quarter ended March 31, 2022 and provided a clinical update on its Phase 3 clinical program of simufilam in Alzheimer’s disease. Simufilam is Cassava Sciences’ lead drug candida